GTx begins Phase prostate cancer IIb/III

GTx (Memphis, Tenn.) began a double-blind, placebo-controlled U.S.

Read the full 80 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE